Name: Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP | Plenosat M2
Availability: InStock

Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP | Pliglim M2 – Advanced Diabetes Management

Managing type 2 diabetes requires consistent blood sugar control to prevent long-term complications such as heart disease, kidney disorders, neuropathy, and vision problems. Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP | Plenosat M2 is a clinically formulated combination therapy designed to provide effective and sustained glycemic control.

What is Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP

Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP is an oral medication that combines two active ingredients to target type 2 diabetes:

Glimepiride: A sulfonylurea that stimulates insulin secretion from pancreatic beta cells, helping the body regulate high blood sugar levels.
Metformin Hydrochloride (Prolonged Release): A biguanide that improves insulin sensitivity in muscles and fat tissue and decreases hepatic glucose production, providing long-lasting glucose control.

The prolonged-release formulation ensures steady absorption, offering sustained blood sugar management throughout the day.

Key Benefits of Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP

Comprehensive Blood Sugar Control
The dual-action combination targets both fasting and postprandial blood glucose levels for effective glycemic control.
Prolonged-Release Formulation
Metformin’s sustained-release design ensures gradual absorption, reducing sudden spikes in blood sugar and providing a smoother daily profile.
Dual Mechanism of Action
Glimepiride stimulates insulin secretion while metformin improves insulin sensitivity, tackling two major causes of hyperglycemia in type 2 diabetes.
Convenient Once-Daily Dosing
The prolonged-release formulation reduces the need for multiple daily doses, improving patient adherence.
Clinically Safe and Effective
Manufactured under strict quality standards, Plenosat M2 is suitable for long-term use and diabetes management.

How Glimepiride and Metformin Hydrochloride Prolonged Release Tablets Work

Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP works via a dual-action mechanism:

Glimepiride: Stimulates insulin release from pancreatic beta cells to help lower elevated blood sugar levels.
Metformin Hydrochloride (Prolonged Release): Enhances peripheral glucose uptake, reduces hepatic glucose production, and maintains stable blood sugar levels over an extended period.

This combined mechanism addresses both insulin deficiency and insulin resistance, offering comprehensive management of type 2 diabetes.

Common Uses of Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP

Management of type 2 diabetes in adults
Patients inadequately controlled with diet, exercise, or single therapy
Control of fasting and postprandial glucose levels
Individuals needing long-term glucose management with sustained effects
Supporting overall metabolic health in diabetes patients

How to Use Glimepiride and Metformin Hydrochloride Prolonged Release Tablets

To maximize the benefits of Plenosat M2:

Take the tablet orally with water, usually once daily with breakfast or as directed by your healthcare provider.
Swallow the tablet whole; do not crush, chew, or break it.
Follow your doctor’s dietary and lifestyle recommendations for optimal glucose control.
Monitor blood glucose levels regularly.
Store in a cool, dry place, away from sunlight and moisture.

Adhering to the prescribed regimen ensures maximum therapeutic benefits.

Who Can Benefit?

Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP is suitable for:

Adults diagnosed with type 2 diabetes
Patients requiring combination therapy for better glucose control
Individuals with high fasting or postprandial blood sugar
Patients seeking convenient once-daily therapy for improved compliance

Always consult a healthcare professional before starting therapy, especially if you have kidney, liver, or heart conditions.

Safety and Precautions

While generally safe, patients taking should observe the following precautions:

Take only as prescribed by your healthcare provider.
Inform your doctor about any history of kidney, liver, or heart disease.
Be vigilant for hypoglycemia, especially when combining with other medications, fasting, or exercising.
Avoid alcohol, as it may increase the risk of lactic acidosis associated with metformin.
Keep the medication out of reach of children.

Potential Side Effects

Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP is typically well-tolerated. Possible side effects include:

Nausea, vomiting, diarrhea, or mild gastrointestinal discomfort
Hypoglycemia, especially if meals are skipped
Headache or dizziness
Rarely, lactic acidosis due to metformin

Patients should immediately report any severe or persistent symptoms to their healthcare provider.

Why Choose Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP?

Plenosat M2 is preferred because:

Provides dual-action control of blood glucose
Prolonged-release metformin ensures stable glucose levels
Controls both fasting and postprandial hyperglycemia
Convenient once-daily dosing improves adherence
Clinically proven safe for long-term management of type 2 diabetes

This makes Glimepiride and Metformin Hydrochloride Prolonged Release Tablets a trusted choice for both healthcare providers and patients.

Tips to Support Diabetes Management

To optimize the effectiveness of:

Follow a balanced diet with controlled carbohydrate intake
Engage in regular physical activity to improve insulin sensitivity
Monitor blood glucose regularly
Avoid skipping doses or sudden dietary changes
Attend periodic check-ups to monitor kidney, liver, and metabolic health

Patient Experience

Patients using Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP report:

Stable blood sugar levels throughout the day
Reduced postprandial blood sugar spikes
Convenience of once-daily dosing
Improved energy levels and overall metabolic health

These experiences highlight the effectiveness and reliability in managing type 2 diabetes.

Conclusion

Type 2 diabetes requires consistent blood sugar management, lifestyle adjustments, and effective medication. Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP offers dual-action therapy with prolonged-release metformin, ensuring stable glucose levels, reducing post-meal spikes, and providing convenient once-daily dosing.

Under proper medical supervision, it supports long-term diabetes management, enhances patient adherence, and promotes overall health, making it an excellent choice for adults with type 2 diabetes.

Frequently Asked Questions (FAQs) About Pliglim M2 Glimepiride and Metformin Prolonged Release Tablets

What is Pliglim M2 (Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP)?

It is an oral combination medicine for type 2 diabetes. It contains glimepiride and prolonged-release metformin hydrochloride. The page text also refers to it as Plenosat M2.

What is this tablet used for?

It is used to manage type 2 diabetes in adults, including people not well controlled with diet, exercise or a single medicine. It helps control both fasting and after-meal blood sugar.

How do glimepiride and metformin work together?

Glimepiride is a sulfonylurea that stimulates the pancreas to release insulin. Metformin improves how the body responds to insulin and reduces sugar made by the liver. Together they address both low insulin release and insulin resistance.

What does prolonged release mean?

The metformin is released slowly, so it is absorbed gradually. This helps provide steadier blood sugar control through the day and can mean fewer tablets are needed each day.

Who can use Pliglim M2, and is a prescription needed?

It is meant for adults diagnosed with type 2 diabetes who need combination therapy. It is a prescription medicine, so use it only on your doctor’s advice.

How should I take Pliglim M2?

Take it by mouth with water, usually with breakfast or as directed by your healthcare provider. Your doctor decides how often you take it. Follow the pack leaflet and do not stop suddenly without talking to your doctor.

Can I crush, chew or break the tablet?

No. Swallow the tablet whole. Crushing, chewing or breaking a prolonged-release tablet can upset how the medicine is released.

What does M2 in the name mean?

M2 is part of the brand name for this glimepiride and metformin combination. Check the pack label for the exact amount of each ingredient, and ask your doctor if you are unsure.

Can I drink alcohol while taking it?

It is best to avoid alcohol. Alcohol may increase the risk of lactic acidosis linked to metformin and can also affect your blood sugar.

Can it cause low blood sugar?

Yes, low blood sugar is possible, especially if you skip meals, fast, exercise heavily or use other diabetes medicines. Be alert for signs such as shakiness or sweating, and ask your doctor what to do. Dizziness can also occur, so take care when driving.

Can people with kidney, liver or heart conditions use it?

Inform your doctor about any history of kidney, liver or heart disease before you start. Your doctor will decide whether this medicine is suitable and arrange check-ups.

Is it suitable during pregnancy or breastfeeding?

Tell your doctor if you are pregnant, planning a pregnancy or breastfeeding. Your doctor will decide the best treatment for you.

What are the possible side effects?

Possible effects include nausea, vomiting, diarrhea, mild stomach discomfort, headache, dizziness and low blood sugar. Lactic acidosis is rare and linked to metformin.

What should I do if I get side effects?

Report any severe or lasting symptoms to your healthcare provider straight away. Do not stop or change your treatment on your own.

What if I miss a dose?

Do not take a double dose to make up for a missed one. Follow your doctor’s advice or the pack leaflet. Avoid skipping doses in general.

Can I take it with other medicines?

Tell your doctor about all medicines and supplements you use. Low blood sugar is more likely when diabetes medicines are combined, so your doctor will check the combination.

Do I still need diet, exercise and check-ups?

Yes. Follow a balanced diet with controlled carbohydrates, stay active, check your blood glucose regularly and attend periodic check-ups of your kidney, liver and metabolic health.

How should I store these tablets?

Store them in a cool, dry place away from sunlight and moisture. Keep the medicine out of the reach of children.

Are there other metformin combinations available?

Yes. Your doctor may consider options such as voglibose, glimepiride and metformin prolonged release tablets, metformin and gliclazide tablets or metformin prolonged release tablets. Browse the wider cardiac and diabetic range or the glimepiride and metformin tablets from Saturn Formulations.

Where can I enquire about Pliglim M2?

Use our contact page to reach the team. If you are interested in a business partnership, see the PCD pharma franchise information from Saturn Formulations.

This information is for general awareness only and is not a substitute for medical advice. Please consult your doctor before using any medicine.